EFSA RECEIVES NOVEL FOOD APPLICATION FOR SYNTHETIC CBD
Jan 04, 2020
A Czech firm submitted a novel food application for the use of a synthetized trans-Cannabidiol in food supplements. The application has been written in the EFSA register of questions meaning that EFSA will assess the safety of the use of the compound under the proposed uses. The application follows an initial novel food application on hemp-derived cannabidiol launched in 2016. With the subsequent application, the company hopes to bypass the distrust around the hemp origin of the substance.
EFSA Register of questions (EFSA-Q-2019-00750) - link
What Should Dietary Supplement Oversight Look Like in the US?
USA
May 16, 2022
Directions on health supplements, nutraceuticals and other health products
India
May 12, 2022
Updates to the dietary supplement ingredient advisory list
USA
May 11, 2022
Draft bill for medical cannabis and industrial hemp
Argentina
May 09, 2022
USA - Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety?
USA
May 09, 2022
USA - Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?
USA
May 09, 2022
Warning letters to companies illegally selling CBD and Delta-8 THC products
USA
May 04, 2022
“Dietary Supplement Listing Act of 2022” introduced in the Senate
USA
Apr 28, 2022
Additional CBD products added to the public list
UK
Apr 27, 2022
Policy regarding N-acetyl-L-cysteine
USA
Apr 22, 2022
Updated list of vitamins, minerals and other nutrients allowed in dietetic products
Peru
Apr 11, 2022
FDA confirms N-acetyl-L-cysteine is excluded from the definition of a dietary supplement
USA
Apr 07, 2022
Assessment of the Impact of Scientific Reports Published by EFSA and GIS on Functional Foods Newly Placed on the Market in Poland
Poland
Apr 07, 2022
FSA takes next step to regulate CBD market
UK
Apr 06, 2022
Laboratories vs. Simply You Pharmaceuticals
Czech Republic
Apr 05, 2022
